Enzyme induction in humans. Clinical aspects— An overview

This publication has 18 references indexed in Scilit:

• Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers.
  British Journal of Clinical Pharmacology, 1979
• Measurement of urinary 6-?-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin
  European Journal of Clinical Pharmacology, 1979
• The effect of enzyme induction on the irreversible binding of ethynyloestradiol to guinea pig liver microsomes
  Life Sciences, 1978
• A direct radioimmunoassay for 6β-hydroxycortisol in human urine
  The Journal of Steroid Biochemistry and Molecular Biology, 1978
• Evidence for the Clara cell as a site of cytochrome P450-dependent mixed-function oxidase activity in lung
  Nature, 1977
• Cytochrome P-450-mediated oxidation of 2-hydroxyestrogens to reactive intermediates
  Biochemical and Biophysical Research Communications, 1976
• Effect of rifampicin.treatment on the metabolism of oestradiol and 17?-ethinyloestradiol by human liver microsomes
  European Journal of Clinical Pharmacology, 1975
• ARE ANTICONVULSANTS ONCOGENIC?
  The Lancet, 1974
• Dose‐dependent enzyme induction
  Clinical Pharmacology & Therapeutics, 1973
• Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man
  Journal of Clinical Investigation, 1969